<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR29">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jackson</surname>
    <given-names>GH</given-names>
   </name>
   <name>
    <surname>Davies</surname>
    <given-names>FE</given-names>
   </name>
   <name>
    <surname>Pawlyn</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Cairns</surname>
    <given-names>DA</given-names>
   </name>
   <name>
    <surname>Striha</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Collett</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Waterhouse</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Kishore</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Garg</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>CD</given-names>
   </name>
   <name>
    <surname>Karunanithi</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Lindsay</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Jenner</surname>
    <given-names>MW</given-names>
   </name>
   <name>
    <surname>Cook</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Kaiser</surname>
    <given-names>MF</given-names>
   </name>
   <name>
    <surname>Drayson</surname>
    <given-names>MT</given-names>
   </name>
   <name>
    <surname>Owen</surname>
    <given-names>RG</given-names>
   </name>
   <name>
    <surname>Russell</surname>
    <given-names>NH</given-names>
   </name>
   <name>
    <surname>Gregory</surname>
    <given-names>WM</given-names>
   </name>
   <name>
    <surname>Morgan</surname>
    <given-names>GJ</given-names>
   </name>
  </person-group>
  <article-title>Lenalidomide is a highly effective maintenance therapy in myeloma patients of all ages; results of the phase III myeloma XI study</article-title>
  <source>Blood</source>
  <year>2016</year>
  <volume>128</volume>
  <fpage>1143</fpage>
  <lpage>1143</lpage>
 </element-citation>
</ref>
